All terms in HP

Label Id Description
Breast microcalcification HP_0040403 [The term breast microcalcification is used to define calcium deposits in the breast with a diameter of less than 1 mm.]
Architectural distortion of breast HP_0040404 [Architectural distortion is defined as an architectural disruption of the normal breast that does not have obvious mass opacities, which may be early signs of breast carcinoma.]
Asymmetric thickening of the nipple-areolar complex HP_0040405 [Thickening of the skin around the nipple with a distribution that is not equal on all sides.]
Perimenopausal HP_0040406 [Perimenopause, or the menopausal transition, encompasses that period of time during which physiologic changes mark progression toward a woman's final menstrual period. This phase begins with the onset of menstrual irregularities and continues until a woman reaches menopause, or one year after amenorrhea has occurred. Perimenopause can last for a variable amount of time, the median of which is four years.]
Nipple localization HP_0040402 [Applies to a sign or symptom that is distributed around the nipples or located in the nipples.]
Mastitis HP_0040407 [Mastitis is defined as an inflammation of the breast and may or may not be accompanied by infection.]
Ameliorated by menopause HP_0040408 [Applies to a sign or symptom that is improved or made more bearable by menopause.]
Fluctuance on palpation HP_0040409 [Yielding to alternate pressure by palpating fingers so as to suggest that the area being felt contains fluid.]
Peripheral dysmyelination HP_0003469 [Defective structure and function of myelin sheaths. Dysmyelination is distinguished from demyleination where there is destruction or damage of previously normal myelination.]
Elevated 8(9)-cholestenol HP_0003465
obsolete Abnormal cholesterol homeostasis HP_0003464
Atlantoaxial instability HP_0003467 [Abnormally increased movement at the junction between the first cervical (atlas) and the second cervical (axis) vertebrae as a result of either a bony or ligamentous anomaly.]
Paradoxical increased cortisol secretion on dexamethasone suppression test HP_0003466
Increased urinary O-linked sialopeptides HP_0003461 [Excretion of peptides conjugated to sialic acid in the urine.]
diterpenoid metabolic process GO_0016101 [The chemical reactions and pathways involving diterpenoid compounds, terpenoids with four isoprene units.]
Decreased circulating total IgA HP_0003460 [Undetectable serum immunoglobulin A level at a value < 5 mg/dL (0.05 g/L).]
Increased extraneuronal autofluorescent lipopigment HP_0003463 [Lipofuscin, a generic term applied to autofluorescent lipopigment, is a mixture of protein and lipid that accumulates in most aging cells, particularly those involved in high lipid turnover (e.g., the adrenal medulla) or phagocytosis of other cell types (e g., the retinal pigment epithelium or RPE; macrophage). This term pertains if there is an increase in the extraneuronal accumulation of lipofuscin (also known as autofluorescent lipoprotein) more than expected for the age of the patient.]
Increased cerebral lipofuscin HP_0011813 [Lipofuscin (age pigment) is a brown-yellow, electron-dense, autofluorescent material that accumulates progressively over time in lysosomes of postmitotic cells, such as neurons and cardiac myocytes. This term pertains if there is an increase in the accumulation of lipofuscin (also known as autofluorescent lipoprotein) more than expected for the age of the patient.]
Elevated 8-dehydrocholesterol HP_0003462
phosphorus metabolic process GO_0006793 [The chemical reactions and pathways involving the nonmetallic element phosphorus or compounds that contain phosphorus.]